Status:
COMPLETED
A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Obesity
Eligibility:
All Genders
30-50 years
Phase:
PHASE2
Brief Summary
To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.
Eligibility Criteria
Inclusion
- Both genders, BMI ≥ 30 kg/m² and \<40 kg/m².
Exclusion
- Known abnormal thyroid hormone levels, or high thyroid stimulating hormone (TSH) level.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT00349635
Start Date
October 1 2004
Last Update
September 3 2007
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 1
Helsinki, Finland
2
Site 3
Kuopio, Finland
3
Site 2
Oulu, Finland